Kaplan Matthew L. (CIK 1895952) reported 3 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-06-12). Recent activity: Buy NVCT (35,000 shares), Buy NVCT (11,000 shares), Buy NVCT (30,000 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-12 | Nuvectis Pharma, Inc. (NVCT) | Director | Buy | 35,000 | $0 |
| 2025-11-06 | Nuvectis Pharma, Inc. (NVCT) | Director | Buy | 11,000 | $64,240 |
| 2025-06-12 | Nuvectis Pharma, Inc. (NVCT) | Director | Buy | 30,000 | $0 |
Source: SEC Form 4 filings · as of 2026-06-12